Helaina
founded in New York by Laura Katz in 2019, Helaina brews human-identical lactoferrin (effera) in Komagataella phaffii and has published 11 papers on it; production has reached metric-ton scale (about 10 million servings per run) through co-manufacturing partners,…
- Country
- United States
FDA GRAS (self-affirmed)
Coverage
| CN | EU | US | |
|---|---|---|---|
| food-alt-protein | ✓ | ✓ | ✓ |
Regulatorsfdaefsa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Precision-fermented infant formula | food-alt-protein | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.